Literature DB >> 18475640

The influence of 2- chlorodeoxyadenosine in combination with tumour necrosis factor-alpha or its mutein on murine leukaemias L1210 and P388.

J Góra-Tybor1, K Warzocha, T Robak.   

Abstract

We investigated the influence of 2-chlorodeoxyadenosine (2-CdA) in combination with tumour necrosis factor-alpha (TNFalpha) or its mutein VI, which differs from the native molecule by N-terminal amino acid composition, on the survival time of mice inoculated with leukaemia L1210 or P388. Groups of mice with leukaemia L1210 and P388 receiving 2-CdA combined with TNFalpha had shorter survival times than animals treated with these agents separately. In contrast, the administration of 2-CdA in conjunction with mutein VI, prolonged the survival of mice inoculated with these leukaemias as compared with animals receiving these agents separately. The results of the present study emphasize the importance of the biological activity of the TNFalpha molecule N-terminus.

Entities:  

Year:  1995        PMID: 18475640      PMCID: PMC2365631          DOI: 10.1155/S0962935195000330

Source DB:  PubMed          Journal:  Mediators Inflamm        ISSN: 0962-9351            Impact factor:   4.711


  14 in total

Review 1.  Two TNF receptors.

Authors:  L A Tartaglia; D V Goeddel
Journal:  Immunol Today       Date:  1992-05

2.  Induction of apoptotic cell death in chronic lymphocytic leukemia by 2-chloro-2'-deoxyadenosine and 9-beta-D-arabinosyl-2-fluoroadenine.

Authors:  L E Robertson; S Chubb; R E Meyn; M Story; R Ford; W N Hittelman; W Plunkett
Journal:  Blood       Date:  1993-01-01       Impact factor: 22.113

Review 3.  Tumor necrosis factor: receptors and inhibitors.

Authors:  H Loetscher; M Steinmetz; W Lesslauer
Journal:  Cancer Cells       Date:  1991-06

4.  Synergistic effects of combination therapy with human recombinant interleukin-2 and tumor necrosis factor in murine tumor models.

Authors:  J L Winkelhake; S Stampfl; R J Zimmerman
Journal:  Cancer Res       Date:  1987-08-01       Impact factor: 12.701

5.  Synthesis and expression in E. coli of the gene for human tumor necrosis factor (h alpha TNF).

Authors:  J Kłysik; A Konarzewska-Zglińska; G Gałazka; B Uznański; A Okruszek; P Guga; A Wilk; M Koziołkiewicz; H Tchórzewski; M Zembala
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  1991       Impact factor: 4.291

Review 6.  Mechanisms of tumor necrosis factor action.

Authors:  S Schütze; T Machleidt; M Krönke
Journal:  Semin Oncol       Date:  1992-04       Impact factor: 4.929

7.  Activation of the AP-1 transcription factor by arabinofuranosylcytosine in myeloid leukemia cells.

Authors:  M A Brach; F Herrmann; D W Kufe
Journal:  Blood       Date:  1992-02-01       Impact factor: 22.113

8.  The interaction of 2-chlorodeoxyadenosine (2-CDA) and interferon alpha (IFN-alpha) on normal and myeloid leukemia hematopoiesis in vitro.

Authors:  T Robak; A Korycka; J Góra-Tybor
Journal:  Leuk Res       Date:  1994-04       Impact factor: 3.156

9.  The effect of tumour necrosis factor-alpha (TNF-alpha) muteins on human neutrophils in vitro.

Authors:  H Tchorzewski; K Zeman; J Kantorski; E Paleolog; M Kahan; M Feldmann; M Kwinkowski; P Guga; B Szymanska; P Parniewski; A Wilk; J Jarosz
Journal:  Mediators Inflamm       Date:  1993       Impact factor: 4.711

10.  A comparison of the Antileukaemic Effects of Recombinant Human Tumour Necrosis Factor-alpha and its Muteins on Leukaemia L1210 and Leukaemia P388 in Mice.

Authors:  K Warzocha; J Góra-Tybor; M Kwinkowski; B Szymańska; T Robak
Journal:  Mediators Inflamm       Date:  1994       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.